The primary role of this cream is to provide supportive, symptomatic management for skin conditions characterized by significant discomfort and dryness. Its therapeutic relevance spans key domains where symptomatic support is appropriate and is considered relevant in contexts involving heightened systemic burden.

---

The product is commonly used for managing symptomatic relief in conditions such as eczema, various forms of dermatitis, scaling skin conditions, and senile pruritus (age-related itch). The cream is applied when appropriate in scenarios where patients experience symptoms related to persistent itching and chronic dryness.

Symptomatic Domains and Patient Benefit

This medicine is primarily used for managing the distressing sensation of pruritus and addressing the cluster of symptoms associated with xerosis, or skin dryness. This application is commonly used when the persistent urge to scratch interferes with daily activities or disrupts sleep, and it may provide support to calm the skin and helps ease the overall symptom load. It contributes to improved comfort during periods of heightened symptoms by supporting the skin barrier and managing irritation, which assists with maintaining functional stability.

---

Quick Fact: Relief for Pruritus and Xerosis
Primary Symptoms Managed	Itching, dryness, flakiness, irritation, and soreness associated with chronic conditions.
Key Patient Benefit	May assist with managing symptoms related to the itch-scratch cycle and contributes to easing the overall symptom load.
Relevant Patient Groups	Adults, older adults, and children with symptoms of dry, itchy, or sensitive skin.

Eligibility for Use

The cream is officially documented as suitable for use by adults, the elderly, and children over the age of one month. Regulatory information states that use is not recommended in infants under one month of age.

---

Absolute Contraindications

The medicine is formally contraindicated and must not be used if a patient has a known hypersensitivity or allergy to the active ingredients (Urea, Lauromacrogols) or any of the product's excipients. Regulatory documents prohibit use in cases of acute erythroderma or on acutely red, oozing, infected, or severely inflamed skin lesions.

---

Pregnancy, Lactation, and Restrictions

Official labeling indicates that the cream may be used during pregnancy. While use is generally permitted during breastfeeding, it is strictly restricted from being applied to the breasts immediately before feeding an infant. There are no specific restrictions documented for patients based on hepatic or renal impairment. Caution is advised as application to broken or inflamed skin may cause irritation.

Interactions with other medicines and products

This section details interaction patterns for E45 Itch Relief (Urea and Lauromacrogols) based strictly on official regulatory prescribing information. The product's interaction profile is minimal due to its topical application and negligible systemic absorption, focusing primarily on localized effects at the skin.

Documented Interaction Patterns

Category	Regulatory Status
Systemic Pharmacokinetic Interactions	None documented. Official sources do not specify interactions involving metabolic enzymes (e.g., CYP), drug transporters, or altered clearance with systemic medicines.
Contraindicated Combinations	None documented. No specific medicinal products are formally classified as contraindicated for co-administration.

Primary Interaction: Topical Permeation Enhancement

The most relevant official interaction involves the active ingredient Urea, which is documented to increase the penetration through the skin barrier of other topically applied medicines. This effect can enhance the exposure of co-administered agents when the cream is used concurrently.

Affected Co-Substances (Explicitly Listed):

• Topical Corticosteroids
• Dithranol
• Fluorouracil

Regulatory cautions advise consideration of this enhancement when using E45 Itch Relief at the same time as other topical prescription or non-prescription medicines. No formal interactions with food, alcohol, or herbal products are documented.

Interacting with Peripheral Sensory Nerve Components

E45 Itch Relief acts through its local anesthetic component, Lauromacrogols (Laureth-9), which targets the voltage-gated sodium channels embedded within the peripheral sensory nerve membranes of the skin. This interaction influences the cascade of electrical signaling events. Lauromacrogol's action on the nerve membrane is associated with stabilizing the resting membrane potential and reducing the excitability required to generate an action potential. This mechanism acts to change the biophysical state of the targeted neural pathways.

---

Action on Impulse Conduction Cascades

This targeted mechanism operates within the molecular cascades that govern nerve excitability, modifying the early electrical steps required for signal transmission. The component directly alters pathway activity by preventing the necessary influx of sodium ions through the channels. This inhibition limits the generation and propagation of the nerve impulse along the axon. This activity limits the transmission of signals that originate from heightened peripheral nerve activation and influences the dynamics of nerve transmission resulting from elevated excitability. The mechanism is associated with a rapid kinetic profile of action at the peripheral nerve membrane.

How E45 Itch Relief is Used

The general principles for the administration of E45 Itch Relief Cream are specified by standard guidelines, indicating the route, frequency, and appropriate patient population for this topical preparation. This information defines the standard usage protocol for the cream.

---

Administration Scope

The cream is intended exclusively for topical application to the skin, strictly for external use only. The application is directed to the entire affected area of the skin, consistent with a treatment pattern that covers the symptomatic site rather than being based on a calculated mass or volume.

---

Official Dosing and Frequency

Instruction	Description
Route	Topical application
Frequency	Applied twice a day
Dosing Area	The entire affected area of the skin

The standard frequency of use is set at twice a day, establishing a fixed daily schedule for maintaining coverage over a 24-hour period. The duration of use is not fixed but remains dependent on the clinical response of the underlying skin condition, which permits continuation as a follow-up treatment for conditions such as pruritus and eczema.

---

Population Rules and Constraints

The cream is approved for use in adults and children (including infants) over the age of 1 month. No modification to the standard twice-daily application regimen is required for older adults or the pediatric population (over 1 month). The administration protocol requires no special preparation steps and is constrained only by the requirement that it is applied topically to the affected area.

E45 Itch Relief Cream: Evidence Overview

E45 Itch Relief Cream is formulated with two key components studied for their effects on dry and irritated skin conditions: Urea and Lauromacrogols.

---

Components and Mechanism of Action

Component	Concentration	Primary Effect Studied
Urea	5.0% w/w	Humectant/Moisturiser (supports water retention in the skin)
Lauromacrogols	3.0% w/w	Antipruritic (local anesthetic properties studied for their effect on relieving itch)

Urea is a naturally occurring moisturizing factor in the skin. Studies indicate that the topical application of urea can increase the capacity of the outermost layer of the skin (the horny layer) to retain water, contributing to skin hydration. This effect is relevant for managing dryness associated with conditions like eczema and dermatitis.

Lauromacrogols function as a local anesthetic agent. Research into its application focuses on its potential to disrupt the sensory signals that cause the sensation of itching (pruritus), thereby providing symptomatic relief.

---

Clinical Profile and Safety

Clinical trials have investigated E45 Itch Relief Cream for the management of itching and skin irritation caused by various dry skin conditions, including eczema, dermatitis, and pruritus. The formulation is designed to provide dual action: addressing the sensation of itch while simultaneously rehydrating dry, damaged skin.

Safety data generally indicate that the cream is well-tolerated when used as directed. Reported side effects, while rare, may include localized application site reactions such as a burning sensation or redness, particularly if applied to broken or inflamed skin. The product has been evaluated for use in adults and children over the age of one month.

Key Studies & References

1. Emollients and Moisturizers (Moisturisers)
2. Emollients - National Eczema Society

Common questions about E45 Itch Relief (FAQ)

Q: What is the main difference between E45 Itch Relief Cream and the standard E45 Moisturising Cream?

E45 Itch Relief Cream is formulated as a dual-action product. According to official product information, it contains Lauromacrogols (an ingredient studied for its anti-itch, local anesthetic properties) and Urea (a moisturiser). The standard E45 Cream, conversely, contains emollients such as soft paraffin, liquid paraffin, and in some formulations, Lanolin.

Q: Does E45 Itch Relief Cream contain corticosteroids or other prescription-strength ingredients?

The active ingredients listed in regulatory documents are Urea (a moisturising agent) and Lauromacrogols (an anti-itch agent). Official product information does not list corticosteroids or other specific prescription-strength ingredients as components.

Q: Are there different versions of E45 Itch Relief, such as a cream, a gel, or a mousse?

Official product information indicates that the E45 Itch Relief product line is available in several formulations. These include the Cream, a Gel, and a Cool Mousse.

Q: Can E45 Itch Relief Cream be safely applied to the face and other sensitive areas?

The official product labeling indicates that the cream is generally suitable for application to the face and hands. However, mandatory warnings state that contact with the eyes and mucous membranes (such as the inside of the nose or mouth) must be avoided.

Q: Is it safe to use E45 Itch Relief on very sensitive or thin skin areas?

The cream is described as being perfume-free and dermatologically tested. However, official warnings note that the product contains excipients, such as Benzyl alcohol and Cetyl alcohol, which may cause localized skin reactions like contact dermatitis in sensitive individuals.

Q: How quickly can a user generally expect E45 Itch Relief Cream to start relieving itching?

The Lauromacrogols active ingredient is a topical anesthetic that acts on the peripheral nerves to influence the sensation of itching. Official claims indicate the ingredient provides fast relief or instant soothing of the itch sensation.

Q: How long does the anti-itch effect of one application of E45 Itch Relief typically last?

The Lauromacrogol component provides temporary relief of the itch sensation. The cream is typically applied twice daily. The Urea component is associated with providing up to 24-hour hydration to the skin.

Q: Is E45 Itch Relief Cream safe to use during pregnancy?

Regulatory documents state that people who are pregnant or trying to become pregnant must consult a doctor or pharmacist before using this product. This caution is based on standard regulatory precautions.

Q: Are there specific preservatives in the cream that commonly cause local skin reactions?

Official excipients lists identify ingredients like Benzyl alcohol and Cetyl alcohol. Warnings state that these components may cause local skin reactions such as contact dermatitis in some users.

Q: Is E45 Itch Relief designed to treat the underlying cause of itching?

The cream is described as providing a dual action. Lauromacrogols provide symptomatic anti-itch relief, and Urea addresses the underlying dry skin conditions that cause the irritation.

Q: Can a person who is allergic to Lanolin use E45 Itch Relief Cream?

According to the official ingredients list, E45 Itch Relief Cream does not list Lanolin or Anhydrous Lanolin as an ingredient. However, individuals with known allergies are advised to check the full list of excipients.

Q: Is E45 Itch Relief considered non-comedogenic (does it block pores)?

Official product claims describe the E45 Itch Relief Cream as a non-greasy formulation. The regulatory documents do not specifically use the term 'non-comedogenic'.

Q: Can E45 Itch Relief Gel be stored in the refrigerator for a cooling effect?

The official product information for the E45 Itch Relief Gel explicitly notes that the product may be stored in the fridge for an extra cooling sensation. This is described as an optional handling suggestion.

Q: Does the cream contain ingredients like parabens or sulfates?

The official regulatory excipients list for E45 Itch Relief Cream does not contain any ingredients explicitly identifiable as parabens or sulfates.

Q: Can E45 Itch Relief Cream be used on areas of skin affected by mild sunburn?

Official warnings state that the cream is not to be used on acutely red, oozing, infected, or inflamed skin. The application site restrictions require caution when considering use on sunburned skin.

Q: What should a user do if the appearance of the cream (color or smell) changes?

If you notice anything unusual happens with the cream or if you suspect a reaction, the Patient Information Leaflet directs users to stop using the product and consult a healthcare professional.

Q: Can E45 Itch Relief be used in conjunction with other E45 products, like the shower cream?

Official brand information indicates that the cream may be used in conjunction with E45 cleansing products (such as E45 Shower Cream) as part of a complete emollient regimen.

Official Storage and Disposal Requirements

E45 Itch Relief Cream must be stored according to specific regulatory requirements to maintain its stability and ensure safety.

---

Storage Conditions

• The cream must be stored below 25 C (not above 25 C) to preserve the product's integrity.
• The product must be kept out of the sight and reach of children, a mandatory requirement for all medicines.
• Store the cream in its original container until use.

Special Handling and Disposal

A critical safety instruction is the fire hazard warning associated with the cream. Users must not smoke or go near naked flames while applying the product, as clothing and bedding that have contacted the cream burn more easily.

For disposal, unused or expired E45 Itch Relief must not be thrown away in household waste or wastewater. It must be discarded according to local requirements for medicinal products.